Metformina Ratiopharm

Metformin, the active ingredient in Metformina Ratiopharm, is a Biguanide presented as a tablet for oral use. It is used to improve blood glucose control in adults with type 2 diabetes mellitus. The medication works by decreasing hepatic glucose production and enhancing peripheral insulin sensitivity, helping to lower elevated blood sugar levels.

GNH USA supplies Metformina Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to strict quality standards and provides reliable sourcing for global healthcare providers, ensuring product integrity throughout the supply chain.

Metformina Ratiopharm (metformin) is employed in the management of disorders related to impaired glucose regulation.

- Type 2 diabetes mellitus: improves glycemic control by lowering fasting and post‑prandial blood glucose. - Prediabetes (impaired glucose tolerance): helps delay progression to overt diabetes when combined with lifestyle measures. - Polycystic ovary syndrome: may improve insulin resistance and restore ovulatory function in affected women.

Metformina Ratiopharm may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea - Diarrhea - Abdominal discomfort - Metallic taste - Loss of appetite - Flatulence

Serious or Rare Side Effects: - Lactic acidosis - Severe hypoglycemia (when combined with other glucose‑lowering agents) - Hepatic dysfunction - Allergic skin reactions (rash, urticaria) - Acute pancreatitis - Anemia or neutropenia

When prescribing Metformina Ratiopharm, clinicians should consider several precautionary measures to ensure patient safety.

- Renal function: assess creatinine clearance before initiation and periodically. - Hepatic impairment: avoid in patients with significant liver disease. - Cardiovascular status: monitor in patients with heart failure. - Concomitant alcohol use: advise limitation due to increased lactic acidosis risk. - Vitamin B12 levels: consider periodic monitoring during long‑term therapy. - Store at ambient temperature: keep below 25°C in original container, protect from moisture.

Metformina Ratiopharm can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Iodinated contrast agents (risk of acute renal failure and lactic acidosis) - Cimetidine (increases metformin plasma levels) - Nifedipine (may raise metformin concentrations) - Loop or thiazide diuretics (enhance risk of renal impairment) - Systemic corticosteroids (may reduce glycemic control)

Moderate Interactions (Monitor Closely): - Beta‑blockers (mask hypoglycemia symptoms) - ACE inhibitors or ARBs (potential renal function impact) - Statins (rare increase in metformin levels) - Oral contraceptives (possible alteration of glucose metabolism) - Protease inhibitor antiretrovirals (may affect metformin clearance)